Austin Health

Title
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study.
Publication Date
2021-03
Author(s)
Cho, Yeoungjee
Bello, Aminu K
Levin, Adeera
Lunney, Meaghan
Osman, Mohamed A
Ye, Feng
Ashuntantang, Gloria E
Bellorin-Font, Ezequiel
Gharbi, Mohammed Benghanem
Davison, Sara N
Ghnaimat, Mohammad
Harden, Paul
Htay, Htay
Jha, Vivekanand
Kalantar-Zadeh, Kamyar
Kerr, Peter G
Klarenbach, Scott
Kovesdy, Csaba P
Luyckx, Valerie
Neuen, Brendon
O'Donoghue, Donal
Ossareh, Shahrzad
Perl, Jeffrey
Rashid, Harun Ur
Rondeau, Eric
See, Emily J
Saad, Syed
Sola, Laura
Tchokhonelidze, Irma
Tesar, Vladimir
Tungsanga, Kriang
Kazancioglu, Rumeyza Turan
Yee-Moon Wang, Angela
Yang, Chih-Wei
Zemchenkov, Alexander
Zhao, Ming-Hui
Jager, Kitty J
Caskey, Fergus J
Jindal, Kailash K
Okpechi, Ikechi G
Tonelli, Marcello
Harris, David C
Johnson, David W
Subject
Epidemiology
health care delivery
health policy
kidney failure
peritoneal dialysis
Type of document
Journal Article
DOI
10.1053/j.ajkd.2020.05.032
Abstract
Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe. A cross-sectional survey. Stakeholders including clinicians, policymakers, and patient representatives in 182 countries convened by the International Society of Nephrology (ISN) between July and September 2018. PD use, availability, accessibility, affordability, delivery and reporting of quality outcome measures. Descriptive statistics RESULTS: Responses were received from 160 (88%) countries; 313 participants (nephrologist n=257 [82%], non-nephrologist physician n=22 [7%], other health professional n=6 [2%], administrator/policy maker/civil servant n=17 [5%], other n=11 [4%]); from 156 (86%) countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 countries (19%), particularly in Africa (20/41) and other low-income (15/22) countries. In 69% of countries, PD was the initial dialysis modality for ≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1-25% of treatment costs and higher (>75%) co-payments were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges/day or equivalent on automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes. Low responses from policymakers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data. Large inter- and intra-regional disparities exist in PD availability, accessibility, affordability, delivery and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.
Link
Citation
American Journal of Kidney Diseases 2021; 77(3): 315-325
Jornal Title
American Journal of Kidney Diseases

Files:

NameSizeformatDescriptionLink